My Member
Message Center
trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
-
COVID-19 jab technology to be used in cancer fight
Cancer jabs that use COVID-19 vaccine technology are about to enter human trials in Europe.
2021-09-10 -
Chinese COVID-19 vaccine V-01 enters phase-III trials in Philippines
A recombinant COVID-19 fusion protein vaccine (V-01) developed and manufactured in China has been approved for phase-III clinical trials in the Philippines.
2021-09-03 -
Chinese kit can test for novel coronavirus and flu
The first testing kit granted market approval in China that can screen people for both the novel coronavirus and the influenza virus. [Photo/3DMed Diagnostics]
2021-08-26 -
Inhaled vaccine shows signs of promise
A two-dose inhaled COVID-19 vaccine developed by Chinese researchers appears to be safe and capable of eliciting strong immune responses comparable to those of its one-dose injected counterpart, a preliminary study released this week said.
2021-07-30 -
Hospitals to beef up TCM usage to boost integration with Western medicine
All tertiary general hospitals in China will be required to set up a traditional Chinese medicine department, and all secondary hospitals will be encouraged to build TCM departments, a health official said on Friday.
2021-07-26 -
Researchers share results from ongoing municipal science and technology project
Shanghai has achieved major breakthroughs in future intelligent technology fields, researchers in charge of a major municipal science and technology project said on Saturday.
2021-07-13 -
Study: Effective vaccine response among young
The domestic COVID-19 vaccine developed by Sinovac Biotech is safe and can elicit a strong antibody response in people aged 3 to 17 in early and mid-stage clinical trials, according to a study published recently in a medical journal.
2021-07-12 -
Sinovac vaccine 'well tolerated, safe and induced humoral responses' in minors aged 3-17
The world's first trial results on minors aged 3-17 showed China's inactivated COVID-19 vaccine produced by Sinovac had good safety, tolerability, and immunogenicity in youths aged 3-17 years, the Global Times learnt from Sinovac on Tuesday.
2021-06-30 -
Efficacy of Sinopharm vaccines tops 70%, study finds
Domestic drugmaker Sinopharm's two vaccines are both more than 70 percent effective against symptomatic cases of COVID-19, according to a study published on Wednesday on the world's first third-stage clinical trial of inactivated vaccines.
2021-05-28 -
China's innovative lung cancer drug application accepted for review by US FDA
Chinese drugmaker Innovent Biologics, Inc. and the US-based pharmaceutical firm Eli Lilly and Company announced that FDA accepted for review an application for Sintilimab, an innovative lung cancer drug jointly developed by the two companies.
2021-05-25FDA